Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

THC and CBD: Similarities and differences between siblings
Nephi Stella
Neuron (2023) Vol. 111, Iss. 3, pp. 302-327
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Mauro Maccarrone, Vincenzo Di Marzo, Jürg Gertsch, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 885-958
Open Access | Times Cited: 88
Efficacy of cannabidiol alone or in combination with Δ‐9‐tetrahydrocannabinol for the management of substance use disorders: An umbrella review of the evidence
Bertrand Redonnet, Filiz Eren, Guillaume Avenin, et al.
Addiction (2025)
Open Access | Times Cited: 2
Inhibiting degradation of 2-arachidonoylglycerol as a therapeutic strategy for neurodegenerative diseases
Chu Chen
Pharmacology & Therapeutics (2023) Vol. 244, pp. 108394-108394
Open Access | Times Cited: 27
Novel rapid treatment options for adolescent depression
Sandra Ledesma‐Corvi, Jordi Jornet-Plaza, Laura Gálvez‐Melero, et al.
Pharmacological Research (2024) Vol. 201, pp. 107085-107085
Open Access | Times Cited: 9
A lactate-dependent shift of glycolysis mediates synaptic and cognitive processes in male mice
Ignacio Fernández‐Moncada, Gianluca Lavanco, Unai B. Fundazuri, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Therapeutic potential of cannabidiol polypharmacology in neuropsychiatric disorders
Olivier J. Manzoni, Antonia Manduca, Viviana Trezza
Trends in Pharmacological Sciences (2025)
Open Access | Times Cited: 1
Select Minor Cannabinoids from Cannabis sativa Are Cannabimimetic and Antinociceptive in a Mouse Model of Chronic Neuropathic Pain
Abigail M. Schwarz, Dea Kobeci, Jessica Mancuso, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 391, Iss. 2, pp. 214-221
Open Access | Times Cited: 7
Anti-inflammatory effects of cannabidiol in early stages of neuroinflammation induced by high-fat diet in cerebral cortex of rats
Aleksandra Opęchowska, Kacper Karpiuk, Andrii Zahorodnii, et al.
Toxicology and Applied Pharmacology (2024) Vol. 484, pp. 116856-116856
Open Access | Times Cited: 4
Δ9-Tetrahydrocannabinol (THC): A Critical Overview of Recent Clinical Trials and Suggested Guidelines for Future Research
Peter Pressman, A. Wallace Hayes, Julia Hoeng, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1540-1540
Open Access | Times Cited: 4
Cannabis-Based Phytocannabinoids: Overview, Mechanism of Action, Therapeutic Application, Production, and Affecting Environmental Factors
Marta Jurga, Anna Jurga, Kacper Jurga, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11258-11258
Open Access | Times Cited: 4
Entourage effects of non-psychotropic cannabinoids (npCBs) on visceral sensitivity in experimental colitis
Kristofer Svendsen, Amyaouch Bradaia, María A. Gandini, et al.
Journal of Pharmacology and Experimental Therapeutics (2025) Vol. 392, Iss. 3, pp. 103389-103389
Closed Access
CBD for pets: navigating quality assurance, safety standards, and marketing strategies
Hannah Rideout, A. J. C. Cook, Anthony D. Whetton
Journal of Cannabis Research (2025) Vol. 7, Iss. 1
Open Access
Maladaptive Peripheral Ketogenesis in Schwann Cells Mediated by CB1R Contributes to Diabetic Neuropathy
Weizhen Li, Tuo Yang, Ningning Wang, et al.
Advanced Science (2025)
Open Access
Therapeutic potential of cannabinoids in neurological conditions: a systematic review of clinical trials
Alqassem Y. Hakami, Fahad S. Alshehri
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Involvement of CB1R and CB2R Ligands in Sleep Disorders and Addictive Behaviors in the Last 25 Years
Marcel Pérez-Morales, Rodolfo Espinoza-Abad, Fabio García‐García
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 266-266
Open Access
EFFICACY AND SAFETY OF CANNABINOIDS IN PATIENTS WITH NEUROPATHIC PAIN (LITERATURE REVIEW)
M.V. Кhaitovych, О.М. Місюра
Medical Science of Ukraine (MSU) (2025) Vol. 21, Iss. 1, pp. 158-166
Open Access
Considering Long-Acting Synthetic Cannabidiol for Chronic Pain: A Narrative Review
Paul J. Christo, Eugene Vortsman, Christopher Gharibo, et al.
Cureus (2025)
Open Access
A Systematic Review of Cannabis and Anxiety: Chicken or Egg?
Lily G. Blyth, Chris J. Seal, Maryam Sorkhou, et al.
Current Addiction Reports (2025) Vol. 12, Iss. 1
Closed Access
Acute cannabis intoxication among the paediatric population
Ginevra Malta, Giuseppe Albano, Gianluca Lavanco, et al.
Frontiers in Toxicology (2025) Vol. 7
Open Access
Cannabinoid agonist WIN55,212-2 prevents scopolamine-induced impairment of spatial memory in rats
Marta Moreno‐Rodríguez, Iker Bengoetxea de Tena, Jonatan Martínez‐Gardeazabal, et al.
European Journal of Pharmacology (2025), pp. 177612-177612
Closed Access
Effect of cannabinoids on glutamate levels in the human brain: a systematic review and meta-analysis
Berzenn Urbi, Vincent Sapaen, Ian Hughes, et al.
Journal of Cannabis Research (2025) Vol. 7, Iss. 1
Open Access
The role of cannabidiol in aging
Beibei Ni, Yanying Liu, Meng Dai, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115074-115074
Open Access | Times Cited: 10
Beneficial effects of cannabidiol from Cannabis
Sullim Lee, Yunjeong Lee, Yunseo Kim, et al.
Applied Biological Chemistry (2024) Vol. 67, Iss. 1
Open Access | Times Cited: 3
An enquiry to the role of CB1 receptors in neurodegeneration
Ignacio Fernández‐Moncada, Abel Eraso‐Pichot, Tommaso Dalla Tor, et al.
Neurobiology of Disease (2023) Vol. 184, pp. 106235-106235
Open Access | Times Cited: 9
Therapeutic potentials of cannabidiol: Focus on the Nrf2 signaling pathway
Marjan Talebi, Mohammad Mehdi Sadoughi, Seyed Abdulmajid Ayatollahi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115805-115805
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top